An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection

NCT07528040 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease (CD)

Interventions

DRUG: Guselkumab

Sponsor

Shanghai 10th People's Hospital

Collaborators

[object Object]